Normocarb HF
FDA Approves Procysbi for Rare Genetic Condition »
"The U.S. Food and Drug Administration today approved Procysbi (cysteamine bitartrate) for the management of nephropathic cystinosis in children and adults. Procysbi was granted orphan product designation because it is intended to treat a rare dis"...
Read the FDA Approves Procysbi for Rare Genetic Condition article »
Normocarb HF
CLINICAL PHARMACOLOGY
Mechanism of Action
NORMOCARB HF™ is a pharmacologically inactive solution. The concentrations of electrolytes are chosen to help to restore plasma levels to physiological concentrations.
NORMOCARB HF™ is used as replacement solution to replace water and electrolytes removed during hemofiltration and hemodiafiltration.
Bicarbonate in the solution is used as an alkalinizing buffer to normalize acid-base balance.
Last reviewed on RxList: 7/6/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional Normocarb HF Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
